In support of this, in Ewing sarcoma, the EWSR1‐FLI1‐induced de novo super‐enhancers and oncogenic transcriptional programmes [41, 62] were disrupted and repressed by BRD4 inhibition or depletion [63, 64, 65]. This evidence concerns the gene BRD4 and Ewing sarcoma.